RNU6-276P

Across TCGA pan-cancer cohorts, RNU6-276P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-276P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-276P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-276P expression acts as an unfavorable survival marker.

STAD, PAAD, and BLCA are the cancer types where RNU6-276P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.260	0.601	<.001	117	view →
PAAD	OS	Tertile	II,III,IV	0.233	0.561	.001	72	view →
BLCA	OS	Tertile	All	0.149	0.687	.005	54	view →
SKCM	OS	Tertile	III,IV	0.162	0.703	<.001	45	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
UCS	DFS	Tertile	All	0.153	0.530	.016	36	view →
OV	OS	Tertile	IV	0.008	0.760	<.001	36	view →
KIRC	DFS	Tertile	III,IV	0.210	0.485	.015	24	view →
ESCA	DFS	Tertile	All	0.184	0.535	.027	18	view →
PRAD	DFS	Tertile	All	0.584	0.886	.040	18	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-276P–STAD (OS)

Open the STAD breakdown →